CMND

Clearmind Medicine Inc. Common Shares

CMND
Closed
$2.04
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Country

CA

CEO

Dr. Adi Zuloff-Shani

IPO date

2021

Employees

0

ISIN

CA1850535016

Key stats

Open

$2.00

Volume

55.99K

Market cap

$3.12M

Prev. close

$2.06

Impl / hst vl

-

Open interest

$0.00

$2.00

Day’s Range

$2.04

$0.22

52W Range

$4.66

Valuation

38
Valuation score
Overvalued
P/E
-
P/S
-
P/B
0.27
Current ratio
4.79
Debt / Equity
-0.99
ROE
-143.79%
Gross margin
-
Income growth
-46.88%
FCF growth
15.98

Analysts estimates

Earnings

Q2 ‘26 revenue
$0.00
Q2 ‘26 net income
-$2.05M
Revenue
Net income
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply